Second, Mn SODs consist of a homodimer and homotetramer species each containing a single Mn(III) atom per subunit
Cochrane Database of Systematic Reviews, CD004861
That does not automatically mean it will be the best option for every patient or that it will replace existing medications
Therefore, while GLP-2R action is required for cold stress-induced jejunal villi lengthening, this adaptation is dispensable for body weight gain in the presence of GLP-1R signaling
The biggest difference is that injectable forms might cause minor injection-site reactions like redness or itching, which obviously don't occur with the pill
Realistic timeline summary Best case scenario: FDA approval Q4 2027, commercial launch Q2 2028, widespread pharmacy availability Q3-Q4 2028, insurance coverage decisions finalized Q4 2028